Breaking News, Collaborations & Alliances

Geneseeq, Zai Lab Enter Strategic Cancer R&D Alliance

Aims to advance Zai Lab's cancer drugs through partnerships in clinical trial recruitment, central lab testing, companion diagnostics and marketing.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Geneseeq Technology Inc. and Zai Lab, Ltd. entered a new strategic collaboration in Shanghai, China to facilitate the R&D and commercialization of Zai Lab’s cancer drugs through business partnerships in clinical trial patient recruitment, central lab testing, companion diagnostics development and marketing activities.  Marc Zhao, the co-founder and Chief Operating Officer of Geneseeq, said, “Geneseeq and Zai Lab hope to use this strategic collaboration as the cornerstone to combine ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters